A federal jury in West Virginia on Thursday found medical technology manufacturer C.R. Bard liable for injuries caused by its vaginal-mesh implant. The jury awarded plaintiff Donna Cisson $2 million in compensatory and punitive damages in the first bellwether trial in massive federal multidistrict litigation over the allegedly defective implants.
The case is one of 8,000 that Bard faces related to its line of Avaulta devices used to treat pelvic organ prolapse and stress urinary incontinence in women. Plaintiffs claim the devices erode, causing organ damage and making sexual intercourse painful.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
